Validation of the Elecsys® HIV combi PT assay for screening and reliable early detection of HIV-1 infection in Asia

Journal of Clinical Virology

Volumn 58, Issue 1, 2013, Pages 221-226

  Tao, Chuan Min ^a   Cho, Yunjung ^b   Ng, Kee Peng ^c   Han, Xiaoxu ^d   Oh, Eun Jee ^e   Zainah, Saat ^f   Rozainanee, Mohd Zain ^f   Wang, Lan Lan ^a  

^a SICHUAN UNIVERSITY   (China)

^b Korea University Ansan Hospital   (South Korea)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^d CHINA MEDICAL UNIVERSITY   (China)

^e The Catholic University of Korea   (South Korea)

^f INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Asia; Assay; Elecsys HIV combi PT; Sensitivity; Specificity

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ARTICLE; ASIA; CELL LYSATE; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; EARLY DIAGNOSIS; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; MULTICENTER STUDY; PRIORITY JOURNAL; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VALIDATION STUDY; VIRUS DIAGNOSIS;

EID: 84881554017     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.05.012     Document Type: Article

References (43)

1. UNAID. 2010: A global view of HIV infection. Report on the global AIDS epidemic. Available from: [accessed 27.02.13]. http://www.unaids.org/documents/20101123_2010_HIV_Prevalence_Map_em.pdf.
2. Baijal P., Kort R. XVII International AIDS Conference: from evidence to action-regional focus. J Int AIDS Soc 2009, 12(Suppl. 1):S6-S16.
3. Kariminia A., Chokephaibulkit K., Pang J., Lumbiganon P., Hansudewechakul R., Amin J., et al. Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol 2011, 40:15-24.
4. Ministry of Health, People's Republic of China, Joint United Nations Program on HIV/AIDS, World Health Organization 2011 Estimates for the HIV/AIDS epidemic in China 2011, Available from: http://www.unaids.org.cn/pics/20130521161757.pdf [accessed 05.06.13].
5. Powers K.A., Ghani A.C., Miller W.C., Hoffman I.F., Pettifor A.E., Kamanga G., et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011, 378:256-268.
6. Miller W.C., Rosenberg N.E., Rutstein S.E., Powers K.A. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 2010, 5:277-282.
7. Karris M.Y., Anderson C.M., Morris S.R., Smith D.M., Little S.J. Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. J Clin Microbiol 2012, 50:1874-1878.
8. Crepaz N., Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS 2002, 16:135-149.
9. Fisher J.D., Smith L.R., Lenz E.M. Secondary prevention of HIV in the United States: past, current, and future perspectives. J Acquir Immune Defic Syndr 2010, 55(Suppl. 2):S106-S115.
10. Cohen M.S., Gay C.L., Busch M.P., Hecht F.M. The detection of acute HIV infection. J Infect Dis 2010, 202(Suppl. 2):S270-S277.
11. EU 2009/886/EC: Commission Decision of 27 November 2009 amending Decision 2002/364/EC on common technical specifications for in vitro diagnostic medical devices 2009, Available from: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:318:0025:0040:en:PDF [accessed 27.02.13].
12. Weber B., Orazi B., Ranieri A., Thorstensson R., Bürgisser P., Mühlbacher A., et al. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin Lab 2006, 52:463-473.
13. Malm K., von Sydow M., Andersson S. Performance of the three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus Med 2009, 19:78-88.
14. WHO HIV assays: operational characteristics, report 16 rapid assays 2009, Available from: http://www.who.int/diagnostics_laboratory/publications/Report16_final.pdf [accessed 27.02.13].
15. Ly T.D., Plantier J.C., Leballais L., Gonzalo S., Lemée V., Laperche S. The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection. J Clin Virol 2012, 55:121-127.
16. Mühlbacher A., Schennach H., van Helden J., Hebell T., Pantaleo G., Bürgisser P., et al. Performance evaluation of a new fourth generation HIV combination antigen-antibody assay. Med Microbiol Immunol 2013, 202:77-86.
17. ® HIV combi PT package insert 2011.
18. ® HIV Ag/Ab combo package insert 2006.
19. ® HIV Ag/Ab combo package insert 2009.
20. ® HIV combi package insert 2010.
21. bioMérieux VIRONOSTIKA® HIV Uni-Form II Plus O package insert 2010.
22. ® HIV1/2 package insert 2008.
23. Zhuhai Livzon Diagnostics Inc. Zhuhai Livzon Anti-HIV EIA package insert 2011.
24. Fanales-Belasio E., Raimondo M., Suligoi B., Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanita 2010, 46:5-14.
25. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:W13-W23.
26. Buonaguro L., Tornesello M.L., Buonaguro F.M. HIV-1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol 2007, 81:10209-10219.
27. Song E.Y., Hur M., Roh E.Y., Park M.H., Moon H.W., Yun Y.M. Performances of four fourth-generation human immunodeficiency virus-1 screening assays. J Med Virol 2012, 84:1884-1888.
28. Bischof J.J., Kuruc J.D., Embry J.A., Hatch J.E., Ashton F.A., Schmitz J.L., et al. Prospective study of the ARCHITECT HIV Ag/Ab Combo fourth generation assay to detect HIV infection in sexually transmitted infection clinics. AIDS 2011, 25:1927-1929.
29. Kim S., Lee J.H., Choi J.Y., Kim J.M., Kim H.S. False-positive rate of a "fourth-generation" HIV antigen/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol 2010, 17:1642-1644.
30. Chavez P., Wesolowski L., Patel P., Delaney K., Owen S.M. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol 2011, 52(Suppl 1):S51-S55.
31. ® HIV Ag/Ab Combo assay. J Virol Methods 2010, 170:16-20.
32. Poljak M., Zener N., Seme K., Kristancic L. Particle agglutination test "Serodia HIV-1/2" as a novel anti-HIV-1/2 screening test: comparative study on 3311 serum samples. Folia Biol (Praha) 1997, 43:171-173.
33. Aboud S., Urassa W., Lyamuya E., Mhalu F., Biberfeld G. Evaluation of HIV antibody and antigen/antibody combination ELISAs for use in an alternative confirmatory HIV testing strategy in Dar es Salaam, Tanzania. J Virol Methods 2006, 135:192-196.
34. van Binsbergen J., Keur W., van de Graaf M., Siebelink A., Jacobs A., de Rijk D., et al. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples. J Virol Methods 1997, 69:29-37.
35. van Binsbergen J., Keur W., Siebelink A., van de Graaf M., Jacobs A., de Rijk D., et al. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 Ag detection: a new generation Vironostika HIV Uni-Form II. J Virol Methods 1998, 76:59-71.
36. Kwon J.A., Yoon S.Y., Lee C.K., Lim C.S., Lee K.N., Sung H.J., et al. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays. J Virol Methods 2006, 133:20-26.
37. Kang H.J., Yoo K.H., Kim H.S., Cho H.C. [Evaluation of Abbott fourth generation HIV antigen and antibody assays]. Korean J Lab Med 2006, 26:39-44. [article in Korean].
38. Thompson M.A., Aberg J.A., Cahn P., Montaner J.S.G., Rizzardini G., Telenti A., et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society USA Panel. JAMA 2010, 304:321-333.
39. Losina E., Schackman B.R., Sadownik S.N., Gebo K.A., Walensky R.P., Chiosi J.J., et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 2009, 49:1570-1578.
40. Chinese Medical Association/Chinese Center for Disease Control Prevention Guidelines for diagnosis and treatment of HIV/AIDS in China (2005). Chin Med J (Engl) 2006, 119:1589-1608.
41. Community Forum on AIDS/Hong Kong Advisory Council on AIDS Quality assurance guidelines on HIV voluntary counselling and testing services in community settings 2009, Available from: http://www.info.gov.hk/aids/pdf/g211.pdf [accessed 27.02.13].
42. Poljak M., Smit E., Ross J. 2008 European guideline on HIV testing. Int J STD AIDS 2009, 20:77-83.
43. WHO Service delivery approaches to HIV testing and counseling (HTC): a strategic HTC programme framework 2012, Available from: http://www.who.int/hiv/pub/vct/htc_framework/en/index.html [accessed 27.02.13].